Latest Treatment Options for Individualized Type 2 Diabetes Care
New from the American Association of Nurse Practitioners® (AANP): A free, live webinar on overcoming clinical inertia when caring for patients with diabetes.
Diabetes affects more than 34 million people in the U.S., 90% to 95% of whom have Type 2 diabetes. As a chronic disease, uncontrolled diabetes can lead to serious health problems, such as diabetic nephropathy, vision impairment, podiatric complications, diabetic neuropathy, cardiovascular disease (CVD), stroke and more.
Research has shown that intensive glycemic control in patients with Type 2 diabetes decreases both the onset and progression of microvascular complications. Despite this increased understanding — including how intensive glycemic control can lead to decreased risk of myocardial infarction, microalbuminuria and coronary vascular disease — only 52% patients have their glycated hemoglobin (HbA1c) at or below the American Diabetes Association’s recommended level of 7%.
AANP has a number of resources available for nurse practitioners (NPs) who are treating patients with diabetes or prediabetes, including several tools to help patients make informed treatment decisions and maintain glycemic control. Check out AANP’s endocrinology resources to download one —or all four — of the patient education tools:
- Continuous Glucose Monitoring (CGM) Pocket Guide: Available in English and Spanish, this tool is a comprehensive guide highlighting what patients need to know about CGM devices for diabetes management. It is designed to help patients understand the features and benefits of the devices currently available and to support point-of-care conversations about diabetes management.
- Living With Type 2 Diabetes Flipchart: Created by expert NPs, this popular flipchart provides information for patients to take home and covers topics such as symptoms, diagnosis, healthy eating, physical activity and medications.
- Insulin/GLP-1 RA Combination Medication Handout: Designed to inform patients about the side effects, dosage adjustment and administration of long-acting basal insulin combined with a glucagon-like peptide-1 receptor agonist (GLP-1 RA), this handout also includes a worksheet for NPs to fill out and give to patients to take home.
- Diabetes Medication Patient Handout: This simple yet effective tool offers basic information on diabetes medications, which is necessary for patients to make an informed decision regarding their therapeutic options.
In addition, AANP has more than a dozen endocrinology-related continuing education (CE) activities — made available free for members — in the AANP CE Center, plus free access to evidence-based articles, up-to-date guidelines and other resources about endocrinology at the Journal of the American Association of Nurse Practitioners (JAANP) Resource Center.
Register for the Free AANP Webinar
In GLP-1 Receptor Agonists for Type 2 Diabetes: Incorporating the Latest Treatment Options Into Individualized Care, speakers Dixie Harms and Shannon Idzik, both NPs with expertise in diabetes care, discuss how to support patients in overcoming clinical inertia utilizing the 2020 American Diabetes Association (ADA) treatment algorithm. Three case studies will be presented to help NPs in clinical practice understand how and when to incorporate GLP-1 RAs into practice, set individualized therapeutic goals, achieve rapid attainment of HbA1c targets and help patients maintain glycemic control.
This 1.25-contact hour CE program, which includes 1.25 pharmacology credit, will be hosted on three occasions through the AANP CE Center as a webinar, with a live faculty question-and-answer (Q&A) period directly following each session. A synopsis of the live Q&A will be available once the program is launched in the AANP CE Center. Complete the activity to download an exclusive clinical resource tool for use in your practice!
The first live webinar will take place 11 a.m.–12:30 p.m. ET (10 a.m.–11:30 a.m. CT) on October 30, 2020. Register for free now to save your spot!